Alena Khromava

1.1k total citations
10 papers, 207 citations indexed

About

Alena Khromava is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alena Khromava has authored 10 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health, 6 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Alena Khromava's work include Vaccine Coverage and Hesitancy (7 papers), Influenza Virus Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Alena Khromava is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Influenza Virus Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Alena Khromava collaborates with scholars based in United States, Canada and France. Alena Khromava's co-authors include Katrin Kohl, Robert T. Chen, Rachel B. Eidex, Leisa Weld, Martín S. Cetron, Allison Kennedy, Irene M. Shui, Gabrielle Fowler, Deborah A. Gust and Kenneth K. C. Man and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Vaccine and Pharmacoepidemiology and Drug Safety.

In The Last Decade

Alena Khromava

9 papers receiving 200 citations

Peers

Countries citing papers authored by Alena Khromava

Since Specialization

Citations

This map shows the geographic impact of Alena Khromava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alena Khromava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alena Khromava more than expected).

Fields of papers citing papers by Alena Khromava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alena Khromava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alena Khromava. The network helps show where Alena Khromava may publish in the future.

Co-authorship network of co-authors of Alena Khromava

This figure shows the co-authorship network connecting the top 25 collaborators of Alena Khromava. A scholar is included among the top collaborators of Alena Khromava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alena Khromava. Alena Khromava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Application of a Language Model Tool for COVID-19 Vaccine Adverse Event Monitoring Using Web and Social Media Content: Algorithm Development and Validation Study 2024 ·PubMed ·Chathuri Daluwatte, Alena Khromava, Yuning Chen, Laurence Serradell, (unknown), (unknown), Cliona Molony, Juhaeri Juhaeri	0
2	Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases 2022 ·Vaccine ·(unknown), (unknown), Chunshen Pan, (unknown), Alena Khromava, (unknown)	5
3	Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety 2021 ·Pharmacoepidemiology and Drug Safety ·Katherine Duszynski, James H. Stark, Catherine Cohet, Wan‐Ting Huang, Ju‐Young Shin, Edward Chia‐Cheng Lai, Kenneth K. C. Man, Nam‐Kyong Choi, Alena Khromava, Tomomi Kimura, Kui Huang, Sawaeng Watcharathanakij, Sonali Kochhar, Robert T. Chen, Nicole Pratt	8
4	Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry 2021 ·Influenza and Other Respiratory Viruses ·(unknown), (unknown), Anju Shrestha, Tamala Mallett Moore, Alena Khromava	6
5	Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry 2021 ·Human Vaccines & Immunotherapeutics ·Charlotte Switzer, Ilia Tikhonov, Alena Khromava, Vitali Pool, Linda E. Lévesque	2
6	Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines 2019 ·Vaccine ·Miriam Sturkenboom, Priya Bahri, (unknown), Tyra Grove Krause, Susan Hahné, Alena Khromava, M Kokki, Piotr Kramarz, Xavier Kurz, Heidi J. Larson, Simon de Lusignan, (unknown), (unknown), Lina Titievsky, Vincent Bauchau	17
7	Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy 2012 ·American Journal of Obstetrics and Gynecology ·Alena Khromava, Christopher J. Cohen, (unknown), Niranjan Kanesa-thasan, Antonio Crucitti, Harry Seifert	7
8	Vaccine safety perceptions and experience with adverse events following immunization in Uzbekistan 2007 ·Public Health ·Gabrielle Fowler, Eric Weintraub, Allison Kennedy, Elizabeth T. Luman, Irene M. Shui, Alena Khromava, Katrin Kohl, Deborah A. Gust	3
9	Vaccine safety perceptions and experience with adverse events following immunization in Kazakhstan and Uzbekistan: A summary of key informant interviews and focus groups 2007 ·Vaccine ·Gabrielle Fowler, Allison Kennedy, (unknown), Katrin Kohl, Alena Khromava, (unknown), Irene M. Shui, Deborah A. Gust	16
10	Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events 2005 ·Vaccine ·Alena Khromava, Rachel B. Eidex, Leisa Weld, Katrin Kohl, (unknown), Robert T. Chen, Martín S. Cetron	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact